KOIOS MEDICAL IS GOING PUBLIC

Harnessing the power of AI-driven diagnostics, Koios Medical delivers its “Smart Ultrasound™” software to empower radiologists with early, accurate detection of breast and thyroid cancer while streamlining workflow. With FDA clearance and CE mark approval, their innovative platform supports physicians in making smarter decisions, reducing unnecessary biopsies, and enhancing patient outcomes

%

%

x

Investment Highlights

Koios Smart Ultrasound® software reduces avoidable biopsy procedures and unnecessary follow-up appointments as well as decreases patient stress, unecessary out-of-pocket expenses from false positives, over-treatment and human error

Integrates seamlessly with existing medical scanners, PACS, and Reporting technologies

200%+ Year-over-Year growth

Over 120 institutional customer adoptions across 28 countries

%

Reduction in false positives

Fewer missed cancers

Increase in productivity

Reduction in follow-up appointments

Market Opportunity

AI-powered software for ultrasound imaging and workflow optimization is poised to super-charge an already booming market

$14B

Predicted growth in global medical imaging over the next decade 

>$2B Worldwide

Total market opportunity for breast and thyroid ultrasound exams

$13B

Projected market value of ultrasound by 2028

$

Scanner

$$$

Enterprise

$$

Individual/Annual Volume

Business Model

Koios Medical offers flexible subscription pricing models, primarily selling to hospitals, health systems and private radiology, and endocrinologist groups based on annual case volume or quantity of physician users of scanners 

Use of Proceeds

Graham Anderson, CFO – Graham is a proven consultant, investor, startup manager, and M&A advisor in the HealthTech industry, previously serving as the President of the NY Venture Capital Association and partner/advisor for multiple health-focused investment firms.

Chad McClennan, President & CEO – A serial successful founder and BusinessWeek Innovation of the Year Award winner, Chad leads Koios Medical with a wealth of experience in business development and consulting for Fortune 500 companies and startups alike. 

Senior Management Team

Products

Koios DS Thyroid 

With a collection of algorithms utilizing over 2 million proprietary ultrasound images and analysis of over 17k features per image, the Koios DS Smart Ultrasound software uses AI to reliably classify and render thyroid cancer risk assessment.

Koios DS Breast

With a collection of algorithms utilizing over 2 million proprietary ultrasound images and analysis of over 17k features per image, the Koios DS Smart Ultrasound software uses AI to reliably classify and render breast cancer risk assessment.

How To Invest in Koios Medical's IPO

3)  Evaluate your investment goals and risk tolerance before placing an order 

4)  Monitor demand and pricing as the IPO unfolds

5)  If your order is in-the-money, you will receive IPO shares directly into your account!

2)  Confirm eligibility for this IPO with your broker or online trading platform 

1)  Do your homework - read the prospectus and view the company's roadshow

A registration statement on Form S-1 relating to the Offering was filed with the Securities and Exchange Commission (the “SEC”) and declared effective. The Offering is made only by means of a prospectus. Copies of the final prospectus may be obtained from the Lead Manager as described in the prospectus. This Event Page and its contents do not constitute an offer to sell or solicitation to buy any securities in jurisdictions where unlawful. Investors should read all SEC filings before investing. © 2025 ClearingBid, Inc. © 2025 Payward, Inc.